KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Shares Outstanding (Diluted Average) (2019 - 2025)

Ginkgo Bioworks Holdings' Shares Outstanding (Diluted Average) history spans 7 years, with the latest figure at $55.5 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 6.87% year-over-year to $55.5 million; the TTM value through Dec 2025 reached $55.5 million, up 6.87%, while the annual FY2025 figure was $55.5 million, 6.87% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $55.5 million in Q4 2025 per DNA's latest filing, up from $54.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $1.9 billion in Q2 2023 to a low of $1.6 million in Q1 2022.
  • Average Shares Outstanding (Diluted Average) over 5 years is $611.4 million, with a median of $54.6 million recorded in 2025.
  • Peak YoY movement for Shares Outstanding (Diluted Average): skyrocketed 119130.92% in 2023, then tumbled 97.38% in 2024.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $1.4 billion in 2021, then tumbled by 96.91% to $42.0 million in 2022, then grew by 15.75% to $48.6 million in 2023, then rose by 6.76% to $51.9 million in 2024, then rose by 6.87% to $55.5 million in 2025.
  • Per Business Quant, the three most recent readings for DNA's Shares Outstanding (Diluted Average) are $55.5 million (Q4 2025), $54.9 million (Q3 2025), and $54.6 million (Q2 2025).